Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,212 All time
- Disclosed funding
- $218.5B 1838 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| N Develops implant for treating articular cartilage defects in the knee | $4.1M | Seed2Seed | Biotech | United States | Investors | |
| AP Develops, constructs, owns, and operates renewable energy assets | $200M | StrategicUndisclosed | Climate tech | United States | Investors | |
| V Provides intelligent software platforms for oncology care | $43M | Undisclosed | Healthtech | United States | Investors | |
| ZI Zepo IntelligenceCompany profile Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. | $15M | Seed | Cybersecurity | United States | Investors | |
| MT Mirador TherapeuticsCompany profile Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | Series B | Biotech | United States | Investors | |
| AA Allos AICompany profile Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies. Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies. | $5M | Seed | AI | United States | Investors | |
| TB Trailhead BiosystemsCompany profile Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine | $20M | Growth | Biotech | United States | Investors | |
| CA Cast AICompany profile Provides automation platform for operating cloud-native and AI workloads at scale Provides automation platform for operating cloud-native and AI workloads at scale | Undisclosed | StrategicUndisclosed | Developer tools | United States | Investors | |
| A AccelsiusCompany profile Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. | $65M | Series B | Hardware | United States | Investors | |
| JT Develops regenerative biologics to restore tissue function | $33.5M | Series B | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Blacksmith, Greptile, Clueso
128rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
102rounds20led - 3General Catalyst
Different, Baba, Modal Labs
68rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
59rounds0led - 5Lightspeed
Warp Sciences, Different, Arena
57rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.